Search research articles
Contact Us
Filters
Showing results (111-120 of 273) with videos related to
Page
of 28
Sort By:
JCO Oncology Practice
|
February 17, 2021
Developing Workshops to Enhance Hope Among Patients With Metastatic Breast Cancer and Oncologists: A Pilot Study
Mirat Shah, Anna Ferguson, Phyllis Dvora Corn, et al.
Journal of the National Cancer Institute
|
December 5, 2003
Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine
Vered Stearns, Michael D Johnson, James M Rae, et al.
Journal of Cancer Survivorship : Research and Practice
|
June 1, 2023
Factors associated with weight gain in pre- and post-menopausal women receiving adjuvant endocrine therapy for breast cancer
Anna-Carson Rimer Uhelski, Amanda L Blackford, Jennifer Y Sheng, et al.
Carcinogenesis
|
May 3, 2019
Intraductal fulvestrant for therapy of ERα-positive ductal carcinoma in situ of the breast: a preclinical study
Guannan Wang, Chuang Chen, Priya Pai, et al.
Frontiers in Pharmacology
|
April 6, 2012
Whole genome amplification of DNA for genotyping pharmacogenetics candidate genes
Santosh Philips, James M Rae, Steffi Oesterreich, et al.
Cancer
|
June 16, 2010
A prospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonography
N Lynn Henry, Jon A Jacobson, Mousumi Banerjee, et al.
Frontiers in Bioengineering and Biotechnology
|
March 12, 2020
Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors
Hanwen Wang, Richard J Sové, Mohammad Jafarnejad, et al.
Biomedicines
|
November 25, 2023
Feasibility of DNA Methylation Age as a Biomarker of Symptoms and Resilience among Cancer Survivors with Multiple Chronic Conditions
Nada Lukkahatai, Jongmin Park, Hejingzi Monica Jia, et al.
Molecular & Cellular Proteomics : MCP
|
September 3, 2015
Phosphoproteomic Analysis Identifies Focal Adhesion Kinase 2 (FAK2) as a Potential Therapeutic Target for Tamoxifen Resistance in Breast Cancer
Xinyan Wu, Muhammad Saddiq Zahari, Santosh Renuse, et al.
Journal of the National Cancer Institute
|
March 8, 2012
CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients
James M Rae, Suzy Drury, Daniel F Hayes, et al.
Page
of 28
Search research articles
Search
Showing results (111-120 of 273) with videos related to
Sort By:
Page
of 28
JCO Oncology Practice
|
February 17, 2021
Developing Workshops to Enhance Hope Among Patients With Metastatic Breast Cancer and Oncologists: A Pilot Study
Mirat Shah, Anna Ferguson, Phyllis Dvora Corn, et al.
Journal of the National Cancer Institute
|
December 5, 2003
Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine
Vered Stearns, Michael D Johnson, James M Rae, et al.
Journal of Cancer Survivorship : Research and Practice
|
June 1, 2023
Factors associated with weight gain in pre- and post-menopausal women receiving adjuvant endocrine therapy for breast cancer
Anna-Carson Rimer Uhelski, Amanda L Blackford, Jennifer Y Sheng, et al.
Carcinogenesis
|
May 3, 2019
Intraductal fulvestrant for therapy of ERα-positive ductal carcinoma in situ of the breast: a preclinical study
Guannan Wang, Chuang Chen, Priya Pai, et al.
Frontiers in Pharmacology
|
April 6, 2012
Whole genome amplification of DNA for genotyping pharmacogenetics candidate genes
Santosh Philips, James M Rae, Steffi Oesterreich, et al.
Cancer
|
June 16, 2010
A prospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonography
N Lynn Henry, Jon A Jacobson, Mousumi Banerjee, et al.
Frontiers in Bioengineering and Biotechnology
|
March 12, 2020
Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors
Hanwen Wang, Richard J Sové, Mohammad Jafarnejad, et al.
Biomedicines
|
November 25, 2023
Feasibility of DNA Methylation Age as a Biomarker of Symptoms and Resilience among Cancer Survivors with Multiple Chronic Conditions
Nada Lukkahatai, Jongmin Park, Hejingzi Monica Jia, et al.
Molecular & Cellular Proteomics : MCP
|
September 3, 2015
Phosphoproteomic Analysis Identifies Focal Adhesion Kinase 2 (FAK2) as a Potential Therapeutic Target for Tamoxifen Resistance in Breast Cancer
Xinyan Wu, Muhammad Saddiq Zahari, Santosh Renuse, et al.
Journal of the National Cancer Institute
|
March 8, 2012
CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients
James M Rae, Suzy Drury, Daniel F Hayes, et al.
Page
of 28